According to FierceBiotech, Pfizer is withdrawing from...

According to FierceBiotech, Pfizer is withdrawing from neuroscience R&D refer Pfizer axing neuroscience jobs, but seeks new VC fund published Jan 7, 2018.

I was fascinated, however, by one of the comments in an unrelated blog post which discussed the cut backs. The comment indicated that in an area of medicine which is a graveyard for investment, Pfizer is simply waiting for someone else to make a big discovery then they will just buy their way back in.

The big prize to be buy back into will be a drug which creates a breakthrough in Alzheimers and Parkinsons. Well to remember about the mechanism of action for Trofinetide and common pathways for neuro degenerative and neuro developmental disorders.